MTOR and neoplasm: In those tumours, combined inhibition of CDK4/6 and signalling pathways upstream of CDK4 activation (MAPK and/or PI3K‐mTOR [50]) is required to fully and durably suppress their proliferation [80, 89, 90, 93, 94].